Skip to content
10-K

Annual Report

Vera Therapeutics, Inc. VERA

0001193125-26-077442

← back to feed
Filed
Feb 26, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2025 · Dec 31, 2025 64.23M sh
Shares Diluted FY 2025 · Dec 31, 2024 55.33M sh
Shares Diluted FY 2025 · Dec 31, 2023 42.71M sh
Stock Repurchased FY 2025 · Dec 31, 2025 $0
Stock Repurchased FY 2025 · Dec 31, 2024 $13K
Stock Repurchased FY 2025 · Dec 31, 2023 $0
Capex FY 2025 · Dec 31, 2025 $630K
Capex FY 2025 · Dec 31, 2024 $972K
Capex FY 2025 · Dec 31, 2023 $63K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$241.1M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$134.68M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$92.18M
Long Term Debt FY 2025 · Dec 31, 2025 $74.84M
Long Term Debt FY 2025 · Dec 31, 2024 $50.69M
Cash And Equivalents FY 2025 · Dec 31, 2025 $354.73M
Cash And Equivalents FY 2025 · Dec 31, 2024 $92.65M
Stockholders Equity FY 2025 · Dec 31, 2025 $604.52M
Stockholders Equity FY 2025 · Dec 31, 2024 $577.16M
Stockholders Equity FY 2025 · Dec 31, 2023 $101.69M
Stockholders Equity FY 2025 · Dec 31, 2022 $76.91M
Current Liabilities FY 2025 · Dec 31, 2025 $53.46M
Current Liabilities FY 2025 · Dec 31, 2024 $25.37M
Total Liabilities FY 2025 · Dec 31, 2025 $130.21M
Total Liabilities FY 2025 · Dec 31, 2024 $78.53M
Current Assets FY 2025 · Dec 31, 2025 $728.88M
Current Assets FY 2025 · Dec 31, 2024 $651.22M
Total Assets FY 2025 · Dec 31, 2025 $734.73M
Total Assets FY 2025 · Dec 31, 2024 $655.68M
Eps Diluted FY 2025 · Dec 31, 2025 −$4.66
Eps Diluted FY 2025 · Dec 31, 2024 −$2.75
Eps Diluted FY 2025 · Dec 31, 2023 −$2.25
Eps Basic FY 2025 · Dec 31, 2025 −$4.66
Eps Basic FY 2025 · Dec 31, 2024 −$2.75
Eps Basic FY 2025 · Dec 31, 2023 −$2.25
Sga Expense FY 2025 · Dec 31, 2025 $100.22M
Sga Expense FY 2025 · Dec 31, 2024 $41M
Sga Expense FY 2025 · Dec 31, 2023 $23.79M
Rd Expense FY 2025 · Dec 31, 2025 $215.26M
Rd Expense FY 2025 · Dec 31, 2024 $126.17M
Rd Expense FY 2025 · Dec 31, 2023 $78.23M
Net Income FY 2025 · Dec 31, 2025 −$299.62M
Net Income FY 2025 · Dec 31, 2024 −$152.15M
Net Income FY 2025 · Dec 31, 2023 −$95.99M
Operating Income FY 2025 · Dec 31, 2025 −$315.47M
Operating Income FY 2025 · Dec 31, 2024 −$167.17M
Operating Income FY 2025 · Dec 31, 2023 −$102.01M